BioSpace News Archive

TScan Therapeutics, Inc. (Nasdaq: TCRX) today announced that the Company will participate in the Cell Therapy Corporate Panel Discussion at the TD Cowen 44th Annual Health Care Conference being held at the Marriott Copley Place in Boston on Wednesday, March 6, 2024 at 9:10 a.m. Eastern Time.

LianBio announced that it has provided notification to The Nasdaq Stock Market, Inc. of its intent to delist the Company’s American Depositary Shares, each representing the right to receive one ordinary share of the Company, from the Nasdaq Global Market.

PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, announced that Company management will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference taking place in Miami Beach, FL, March 12 – 14, 2024.

TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the fourth quarter and year ended December 31, 2023, along with recent company developments.

Aktis Oncology today announced that Matthew Roden , Ph.D., President and Chief Executive Officer, and Shulamit Ron-Bigger , Ph.D., Chief Operating Officer of Aktis Oncology, will participate in Investor meetings at the TD Cowen 44th Annual Healthcare Conference in Boston, Mass. on Monday, March 4, 2024.

Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of key assets of Reverie Labs, which built and used AI/ML tools to accelerate drug discovery. Ginkgo has acquired Reverie’s infrastructure and software for training large-scale AI foundation models.

Access Vascular, Inc. announced that the Infusion Nurses Society has updated its standard of care to include innovative catheter materials, to reduce the risk of vascular access complications.

Fulgent Genetics, Inc. today announced financial results for its fourth quarter and full year ended December 31, 2023.

Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup.

Geron Corporation today reported business highlights and financial results for the fourth quarter and full year 2023.